Delivery Order SPE2DB22D3004-SPE2DB25FSE41
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,289.25 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Qualipita 60 mg tablets (30-count units). This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a competitive, non-set-aside award for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Qualipita 60 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,528.32 under a firm fixed price arrangement with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Qualipita 30 mg tablets in quantities of 30 units, with a ceiling value of $2,393.85. This is a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $8,924.51 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Qualipita 60 mg tablets (30-count units) under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is set to conclude by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $2,875.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on May 23, 2025, with an ultimate completion date of May 27, 2025. This non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $16,035.05 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $10,507.55 to AmerisourceBergen Drug Corp for Qualipita 60 mg tablets (30-count) on May 22, 2025, with completion scheduled for May 23, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Qualipita 60 mg tablets (30-count) with a ceiling value of $6,073.01. This competitively awarded, firm fixed-price delivery order is not associated with any set-aside designation and requires completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Qualipta™ 60 mg tablets (30-count) with a ceiling value of $3,947.30. This is a firm fixed-price delivery order with an ultimate completion date of June 4, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $20,000 to AmerisourceBergen Drug Corp for the supply of Qualipta 60 mg tablets (30-count units). The contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSE41Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,240.64 to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on August 26, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999 and extending through December 2026. The prime contract supports global pharmaceutical supply operations for military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal health systems. AmerisourceBergen's contract portfolio with DLA demonstrates significant capability in delivering specialty medications, brand-name and generic pharmaceuticals, vaccines, and related medical supplies across diverse therapeutic categories to support federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 8/26/25 |